[Federal Register Volume 73, Number 35 (Thursday, February 21, 2008)]
[Notices]
[Page 9592]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-3176]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on December 10, 2007, Johnson 
Matthey, Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, 
West Deptford, New Jersey 08066-1742, made application by letter to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of Lisdexamfetamine (1205), a basic class of controlled 
substance listed in schedule II.
    The company plans to manufacture the listed controlled substance in 
bulk for sale to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration pursuant to 21 CFR 
1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Drug Enforcement 
Administrator, Office of Diversion Control, Federal Register 
Representative (ODL), Washington, DC 20537, or any being sent via 
express mail should be sent to Drug Enforcement Administration, Office 
of Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than April 21, 2008.

    Dated: February 13, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E8-3176 Filed 2-20-08; 8:45 am]
BILLING CODE 4410-09-P